News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
145,396 Results
Type
Article (14237)
Company Profile (9)
Press Release (131150)
Section
Business (39314)
Career Advice (206)
Deals (5306)
Drug Delivery (16)
Drug Development (18396)
Employer Resources (25)
FDA (2820)
Job Trends (3142)
News (65179)
Policy (5272)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 Biotech Bay Standard (1)
Academia (1696)
Accelerated approval (1)
Adcomms (11)
Allergies (13)
Alliances (12519)
ALS (20)
Alzheimer's disease (473)
Antibody-drug conjugate (ADC) (18)
Approvals (2831)
Artificial intelligence (66)
Autoimmune disease (1)
Automation (2)
Bankruptcy (31)
Best Places to Work (2686)
BIOSECURE Act (14)
Biosimilars (8)
Biotechnology (6)
Bladder cancer (19)
Brain cancer (9)
Breast cancer (74)
Cancer (592)
Cardiovascular disease (31)
Career advice (193)
Career pathing (4)
CAR-T (40)
Cell therapy (97)
Cervical cancer (10)
Clinical research (14179)
Collaboration (196)
Compensation (11)
Complete response letters (2)
COVID-19 (1021)
CRISPR (12)
C-suite (54)
Cystic fibrosis (22)
Data (463)
Depression (3)
Diabetes (32)
Diagnostics (1624)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (25)
Drug pricing (19)
Drug shortages (1)
Duchenne muscular dystrophy (12)
Earnings (8923)
Editorial (6)
Employer branding (3)
Employer resources (20)
Events (18572)
Executive appointments (136)
FDA (3047)
Featured Employer (2)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (263)
Gene editing (21)
Generative AI (2)
Gene therapy (84)
GLP-1 (104)
Government (1135)
Guidances (10)
Healthcare (4810)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (11)
Indications (3)
Infectious disease (1053)
Inflammatory bowel disease (31)
Inflation Reduction Act (2)
Influenza (6)
Intellectual property (12)
Interviews (19)
IPO (2707)
IRA (12)
Job creations (544)
Job search strategy (183)
Kidney cancer (5)
Labor market (7)
Layoffs (45)
Leadership (1)
Legal (921)
Liver cancer (20)
Lung cancer (96)
Lymphoma (37)
Machine learning (2)
Management (6)
Manufacturing (49)
MASH (10)
Medical device (2399)
Medtech (2399)
Mergers & acquisitions (2728)
Metabolic disorders (61)
Multiple sclerosis (15)
NASH (4)
Neurodegenerative disease (10)
Neuropsychiatric disorders (2)
Neuroscience (578)
NextGen: Class of 2025 (1598)
Non-profit (1865)
Northern California (428)
Now hiring (5)
Obesity (21)
Opinion (46)
Ovarian cancer (26)
Pain (19)
Pancreatic cancer (17)
Parkinson's disease (32)
Partnered (5)
Patents (27)
Patient recruitment (25)
Peanut (9)
People (15056)
Pharmaceutical (5)
Phase I (4801)
Phase II (6525)
Phase III (4294)
Pipeline (205)
Policy (44)
Postmarket research (546)
Preclinical (2198)
Press Release (18)
Prostate cancer (23)
Psychedelics (10)
Radiopharmaceuticals (47)
Rare diseases (73)
Real estate (1192)
Recruiting (11)
Regulatory (3606)
Reports (9)
Research institute (1863)
Resumes & cover letters (16)
RNA editing (1)
RSV (5)
Schizophrenia (11)
Series A (41)
Series B (16)
Sickle cell disease (19)
Southern California (393)
Spinal muscular atrophy (23)
Sponsored (1)
Startups (1062)
Stomach cancer (3)
Supply chain (12)
Tariffs (2)
United States (4289)
Vaccines (201)
Venture capitalists (11)
Webinars (3)
Weight loss (9)
Women's health (3)
Worklife (3)
Date
Today (25)
Last 7 days (100)
Last 30 days (541)
Last 365 days (6753)
2025 (1712)
2024 (7192)
2023 (8683)
2022 (11510)
2021 (12825)
2020 (12146)
2019 (10897)
2018 (8062)
2017 (7330)
2016 (7401)
2015 (8696)
2014 (6448)
2013 (5316)
2012 (5393)
2011 (5624)
2010 (4800)
Location
Africa (189)
Alabama (31)
Alaska (3)
Arizona (47)
Arkansas (3)
Asia (9152)
Australia (2040)
California (1005)
Canada (332)
China (65)
Colorado (46)
Connecticut (44)
Delaware (34)
Europe (19019)
Florida (209)
Georgia (21)
Idaho (11)
Illinois (113)
India (5)
Indiana (44)
Japan (37)
Kansas (21)
Kentucky (11)
Louisiana (1)
Maine (9)
Maryland (152)
Massachusetts (733)
Michigan (27)
Minnesota (63)
Missouri (25)
Montana (6)
Nebraska (4)
Nevada (4)
New Hampshire (12)
New Jersey (462)
New Mexico (6)
New York (351)
North Carolina (154)
North Dakota (3)
Northern California (428)
Ohio (45)
Oklahoma (5)
Oregon (8)
Pennsylvania (228)
Rhode Island (6)
South America (247)
South Carolina (5)
Southern California (393)
Tennessee (20)
Texas (219)
Utah (30)
Virginia (27)
Washington D.C. (32)
Washington State (125)
West Virginia (1)
Wisconsin (9)
145,396 Results for "hubrecht institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Hubrecht Institute Licenses Flow Eighteen38 Reagent Antibodies for Cancer Research
Flow Eighteen38 and FairJourney Biologics S.A. (FJB), leaders in the discovery and optimization of antibodies, have today announced an agreement with the Hubrecht Institute to harness the potential of FJB’s proprietary llama naïve libraries to develop antibodies to be used as research tools for the group of Hans Clevers.
May 10, 2021
·
2 min read
Press Releases
Shining a spotlight on the Montreal Chest Institute
February 28, 2025
·
5 min read
Press Releases
ImmunityBio Announces Execution of $75 Million Equity Financing with an Institutional Investor
April 8, 2025
·
5 min read
Pharm Country
Renal Research Institute and Karolinska Institutet announce chronic kidney disease management symposium, highlighting new therapeutics
Renal Research Institute, a global leader in dialysis and nephrology research and a subsidiary of Fresenius Medical Care AG, announced together with the Karolinska Institutet a joint symposium, “Prevention of CKD progression: the impact of new therapeutics.” The Karolinska Institutet is one of the world’s leading medical universities.
May 17, 2024
·
3 min read
Press Releases
Parker Institute Appoints Renowned Cancer Immunologist Dr. Ira Mellman as President of Research
April 10, 2025
·
4 min read
Press Releases
Ontario Brain Institute partners with EpiSign to advance diagnosis of rare genetic disorders
March 26, 2025
·
3 min read
Immutep successfully completes institutional placement and institutional component of entitlement offer
Immutep Limited ACN 009 237 889 is pleased to announce the successful completion of its institutional placement and the institutional component of its 1 for 16 pro rata accelerated non-renounceable entitlement offer of new fully paid ordinary shares in Immutep.
June 5, 2024
·
7 min read
Press Releases
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
March 3, 2025
·
2 min read
Press Releases
Joseph Spine Institute Launches Center for Regenerative Spine Medicine, Pioneering Advanced Stem Cell Therapy
April 10, 2025
·
2 min read
Press Releases
Karen Knudsen, MBA PhD, Appointed Chief Executive Officer of the Parker Institute for Cancer Immunotherapy
April 1, 2025
·
7 min read
1 of 14,540
Next
